RE: Share price17 Oct 2023 16:45
Discoman,i think you are correct.if you refer to the RNS of 13th sept 2022, you will see it refers specifically to the covid restrictive regime in china and that this prevented co-high from delivering on its obligations. fum stated they were trying to take steps to remedy the situation, but clearly these failed.not sure if there were any restrictions on riverwood selling during the agreement period,as ire call there were 2 or 3 changes in the holding after the agreement was announced, but i accept that it is very probable that they have been selling since it was formally terminated and the we may simply have to wait for that process to be completed. as an aside,i do not share the opinion of those who have criticised the bod for the failure of the co-high licence.it seems to have been an unfortunate consequence of covid,such as has adversely affected many investments.anyway,regardless of culpability,what seems more important now is the conclusion of a fresh licence for that area and i would reference the statement in the last RNS that there has been significant interest(my words)particularly following the FDA approval.i am therefore, hopeful (and confident) of very positive news here in due course.